Log In
Print
BCIQ
Print
Print this Print this
 

Oncotype DX colon cancer assay

  Manage Alerts
Collapse Summary General Information
Company Genomic Health Inc.
DescriptionDiagnostic assay that analyzes expression of 12 genes to generate a Recurrence Score (RS) to quantify magnitude of chemotherapy benefit and likelihood of recurrence
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict likelihood of colon cancer recurrence and response to treatment; Predict likelihood of recurrence for stage II colon cancer patients following surgery; Predict likelihood of recurrence for stage III colon cancer patients following surgery
Regulatory Designation

Partner

NewBridge Pharmaceuticals Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today